Glycoconjugate vaccines containing peptidoglycan

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/085 (2006.01) A61K 39/39 (2006.01)

Patent

CA 2591442

The present invention relates to vaccines for treating bacterial infections, which vaccines comprise a glycoconjugate immunogen comprising at least one capsular polysaccharide conjugated to a carrier protein, such that the capsular polysaccharide contains an amount of peptidoglycan effective to improve the vaccine's properties.

L'invention concerne des vaccins destinés au traitement d'infections bactériennes, lesquels vaccins comprennent un immunogène glycoconjugué renfermant au moins un polysaccharide capsulaire conjugué à une protéine porteuse, de manière que le polysaccharide capsulaire contient une quantité de peptidoglycane efficace pour améliorer les propriétés du vaccin.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Glycoconjugate vaccines containing peptidoglycan does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycoconjugate vaccines containing peptidoglycan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoconjugate vaccines containing peptidoglycan will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1832223

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.